<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">An atlas of human long non-coding RNAs with accurate 5′ ends</title>
				<funder ref="#_grvBY3f">
					<orgName type="full">Ministry of Education, Culture, Sports, Science and Technology</orgName>
					<orgName type="abbreviated">MEXT</orgName>
				</funder>
				<funder ref="#_XjuCJur #_S75Nk6D">
					<orgName type="full">Ministry of Economy and Competitiveness (MINECO)</orgName>
				</funder>
				<funder>
					<orgName type="full">Spanish Ministry of Economy and Competitiveness</orgName>
				</funder>
				<funder>
					<orgName type="full">RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST</orgName>
					<orgName type="abbreviated">DGT</orgName>
				</funder>
				<funder ref="#_FC9jAHJ">
					<orgName type="full">MEXT Japan</orgName>
				</funder>
				<funder>
					<orgName type="full">FANTOM5</orgName>
				</funder>
				<funder ref="#_kyEtKfp #_UNXvkDB">
					<orgName type="full">Australian Research Council&apos;s Discovery Projects funding scheme</orgName>
				</funder>
				<funder>
					<orgName type="full">Netherlands Brain Bank</orgName>
				</funder>
				<funder>
					<orgName type="full">Cancer Research Trust</orgName>
				</funder>
				<funder>
					<orgName type="full">MACA Ride to Conquer Cancer</orgName>
				</funder>
				<funder>
					<orgName type="full">RIKEN Preventive Medicine and Diagnosis Innovation Program (RIKEN PMI</orgName>
				</funder>
				<funder>
					<orgName type="full">National Human Genome Research Institute of the National Institutes of Health</orgName>
				</funder>
				<funder ref="#_hx5WXMd">
					<orgName type="full">Russian Science Foundation</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2019-11-15">2019 November 15.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Chung-Chau</forename><surname>Hon</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jordan</forename><forename type="middle">A</forename><surname>Ramilowski</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jayson</forename><surname>Harshbarger</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicolas</forename><surname>Bertin</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Cancer Science Institute of Singapore</orgName>
								<orgName type="department" key="dep2">Centre for Translational Medicine</orgName>
								<orgName type="institution">National University of Singapore</orgName>
								<address>
									<addrLine>14 Medical Drive, #12-01</addrLine>
									<postCode>117599</postCode>
									<settlement>Singapore</settlement>
									<country key="SG">Singapore</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Owen</forename><forename type="middle">J L</forename><surname>Rackham</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Life Sciences building</orgName>
								<orgName type="institution">University of Bristol</orgName>
								<address>
									<addrLine>24 Tyndall Avenue</addrLine>
									<postCode>BS8 1TQ</postCode>
									<settlement>Bristol</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Duke-NUS Medical School</orgName>
								<orgName type="laboratory">Program in Cardiovascular and Metabolic Disorders</orgName>
								<address>
									<addrLine>8 College Road</addrLine>
									<postCode>169857</postCode>
									<settlement>Singapore</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julian</forename><surname>Gough</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Computer Science</orgName>
								<orgName type="department" key="dep2">Life Sciences building</orgName>
								<orgName type="institution">University of Bristol</orgName>
								<address>
									<addrLine>24 Tyndall Avenue</addrLine>
									<postCode>BS8 1TQ</postCode>
									<settlement>Bristol</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elena</forename><surname>Denisenko</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute of Natural and Mathematical Sciences</orgName>
								<orgName type="institution">Massey University Auckland</orgName>
								<address>
									<postCode>0632</postCode>
									<settlement>Albany</settlement>
									<country key="NZ">New Zealand</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Schmeier</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute of Natural and Mathematical Sciences</orgName>
								<orgName type="institution">Massey University Auckland</orgName>
								<address>
									<postCode>0632</postCode>
									<settlement>Albany</settlement>
									<country key="NZ">New Zealand</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">M</forename><surname>Poulsen</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Biotechnology Research Institute for Drug Discovery (BRD)</orgName>
								<orgName type="institution">National Institute of Advanced Industrial Science and Technology (AIST)</orgName>
								<address>
									<addrLine>Tsukuba Central 2 1-1-1 Umezono</addrLine>
									<postCode>305-8568</postCode>
									<settlement>Tsukuba</settlement>
									<region>Ibaraki</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jessica</forename><surname>Severin</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marina</forename><surname>Lizio</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hideya</forename><surname>Kawaji</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">RIKEN Preventive Medicine and Diagnosis Innovation Program</orgName>
								<address>
									<addrLine>2-1 Hirosawa</addrLine>
									<postCode>351-0198</postCode>
									<settlement>Wako</settlement>
									<region>Saitama</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Takeya</forename><surname>Kasukawa</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Masayoshi</forename><surname>Itoh</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">RIKEN Preventive Medicine and Diagnosis Innovation Program</orgName>
								<address>
									<addrLine>2-1 Hirosawa</addrLine>
									<postCode>351-0198</postCode>
									<settlement>Wako</settlement>
									<region>Saitama</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">Maxwell</forename><surname>Burroughs</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department">National Center for Biotechnology Information</orgName>
								<orgName type="institution">Human Longevity Singapore Pte. Ltd</orgName>
								<address>
									<settlement>National Singapore</settlement>
									<region>N.B.); GenPhySE</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shohei</forename><surname>Noma</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sarah</forename><surname>Djebali</surname></persName>
							<affiliation key="aff11">
								<orgName type="laboratory">Centre for Genomic Regulation (CRG)</orgName>
								<orgName type="institution">National Institutes of Health</orgName>
								<address>
									<postCode>20894</postCode>
									<settlement>Bethesda</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="institution">The Barcelona Institute of Science and Technology</orgName>
								<address>
									<addrLine>Dr. Aiguader 88</addrLine>
									<postCode>08003</postCode>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tanvir</forename><surname>Alam</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Biomedical Research Park (PRBB)</orgName>
								<orgName type="institution">Universitat Pompeu Fabra (UPF)</orgName>
								<address>
									<addrLine>Dr Aiguader 88</addrLine>
									<postCode>08003</postCode>
									<settlement>Barcelona Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yulia</forename><forename type="middle">A</forename><surname>Medvedeva</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Electrical and Mathematical Sciences and Engineering Division</orgName>
								<orgName type="institution" key="instit1">Computational Bioscience Research Center</orgName>
								<orgName type="institution" key="instit2">King Abdullah University of Science and Technology (KAUST)</orgName>
								<address>
									<postCode>23955-6900</postCode>
									<settlement>Thuwal</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution" key="instit1">Institute of Bioengineering</orgName>
								<orgName type="institution" key="instit2">Research Center of Biotechnology RAS</orgName>
								<address>
									<postCode>119071</postCode>
									<settlement>Moscow</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alison</forename><forename type="middle">C</forename><surname>Testa</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">Vavilov Institute of General Genetic, RAS</orgName>
								<address>
									<postCode>119991</postCode>
									<region>Moscow</region>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leonard</forename><surname>Lipovich</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Center for Molecular Medicine and Genetics</orgName>
								<orgName type="institution" key="instit1">Harry Perkins Institute of Medical Research</orgName>
								<orgName type="institution" key="instit2">QEII Medical Centre and Centre for Medical Research</orgName>
								<orgName type="institution" key="instit3">University of Western Australia</orgName>
								<address>
									<addrLine>Western Australia</addrLine>
									<postCode>6009</postCode>
									<settlement>Nedlands</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Wayne State University</orgName>
								<address>
									<postCode>48201</postCode>
									<settlement>Detroit</settlement>
									<region>Michigan</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chi-Wai</forename><surname>Yip</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Imad</forename><surname>Abugessaisa</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mickaël</forename><surname>Mendez</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Akira</forename><surname>Hasegawa</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dave</forename><surname>Tang</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">Wayne State University</orgName>
								<address>
									<postCode>48201</postCode>
									<settlement>Detroit</settlement>
									<region>Michigan</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Timo</forename><surname>Lassmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">Wayne State University</orgName>
								<address>
									<postCode>48201</postCode>
									<settlement>Detroit</settlement>
									<region>Michigan</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Heutink</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="department">German Center for Neurodegenerative Diseases (DZNE)</orgName>
								<orgName type="institution" key="instit1">Telethon Kids Institute</orgName>
								<orgName type="institution" key="instit2">The University of Western Australia</orgName>
								<address>
									<addrLine>100 Roberts Road</addrLine>
									<postCode>6008 D-72076</postCode>
									<settlement>Subiaco Subiaco Tubingen</settlement>
									<region>Western Australia</region>
									<country>Australia Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Magda</forename><surname>Babina</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Department of Dermatology and Allergy</orgName>
								<orgName type="institution">Charite Universitatsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><forename type="middle">A</forename><surname>Wells</surname></persName>
							<affiliation key="aff22">
								<orgName type="institution" key="instit1">Australian Institute for Bioengineering and Nanotechnology</orgName>
								<orgName type="institution" key="instit2">The University of Queensland</orgName>
								<address>
									<postCode>4072</postCode>
									<settlement>Brisbane</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff23">
								<orgName type="department" key="dep1">Faculty of Medicine</orgName>
								<orgName type="department" key="dep2">Department of Anatomy and Neuroscience</orgName>
								<orgName type="institution">The University of Melbourne</orgName>
								<address>
									<postCode>3010</postCode>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Soichi</forename><surname>Kojima</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">RIKEN CLST (Division of Bio-Function Dynamics Imaging)</orgName>
								<address>
									<postCode>351-0198</postCode>
									<settlement>Wako</settlement>
									<region>Saitama</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yukio</forename><surname>Nakamura</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="department">Cell Engineering Division</orgName>
								<orgName type="institution">RIKEN BioResource Center</orgName>
								<address>
									<postCode>305-0074</postCode>
									<settlement>Tsukuba</settlement>
									<region>Ibaraki</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff26">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Tsukuba</orgName>
								<address>
									<postCode>305-8577</postCode>
									<settlement>Tsukuba</settlement>
									<region>Ibaraki</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Harukazu</forename><surname>Suzuki</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><forename type="middle">O</forename><surname>Daub</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff27">
								<orgName type="department">Department of Biosciences and Nutrition</orgName>
								<address>
									<addrLine>Karolinska Institutet</addrLine>
									<postCode>141 83</postCode>
									<settlement>Huddinge</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michiel</forename><forename type="middle">J L</forename><surname>De Hoon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Erik</forename><surname>Arner</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yoshihide</forename><surname>Hayashizaki</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">RIKEN Preventive Medicine and Diagnosis Innovation Program</orgName>
								<address>
									<addrLine>2-1 Hirosawa</addrLine>
									<postCode>351-0198</postCode>
									<settlement>Wako</settlement>
									<region>Saitama</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Piero</forename><surname>Carninci</surname></persName>
							<email>carninci@riken.jp</email>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alistair</forename><forename type="middle">R R</forename><surname>Forrest</surname></persName>
							<email>alistair.forrest@gmail.com</email>
							<affiliation key="aff0">
								<orgName type="laboratory">RIKEN Center for Life Science Technologies (Division of Genomic Technologies)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">RIKEN Omics Science Center (OSC)</orgName>
								<address>
									<addrLine>1-7-22 Suehiro-cho Tsurumi-ku</addrLine>
									<postCode>230-0045</postCode>
									<settlement>Yokohama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff16">
								<orgName type="institution">Vavilov Institute of General Genetic, RAS</orgName>
								<address>
									<postCode>119991</postCode>
									<region>Moscow</region>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Department of Computer Science</orgName>
								<orgName type="institution" key="instit1">Université de Toulouse</orgName>
								<orgName type="institution" key="instit2">INRA</orgName>
								<orgName type="institution" key="instit3">INPT</orgName>
								<orgName type="institution" key="instit4">ENVT</orgName>
								<address>
									<settlement>Castanet Tolosan</settlement>
									<country>France (S.D.);</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Library of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">An atlas of human long non-coding RNAs with accurate 5′ ends</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-11-15">2019 November 15.</date>
						</imprint>
					</monogr>
					<idno type="MD5">F27D691544F1AB14FA3243407C84D829</idno>
					<idno type="DOI">10.1038/nature21374</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.1" ident="GROBID" when="2025-03-11T09:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Reviewer information Nature thanks M. Gerstein, J. Rinn and the other anonymous reviewer(s) for their contribution to the peer review of this work.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abstract</head><p>Long non-coding RNAs (lncRNAs) are largely heterogeneous and functionally uncharacterized. Here, using FANTOM5 cap analysis of gene expression (CAGE) data, we integrate multiple transcript collections to generate a comprehensive atlas of 27,919 human lncRNA genes with highconfidence 5′ ends and expression profiles across 1,829 samples from the major human primary cell types and tissues. Genomic and epigenomic classification of these lncRNAs reveals that most intergenic lncRNAs originate from enhancers rather than from promoters. Incorporating genetic and expression data, we show that lncRNAs overlapping trait-associated single nucleotide polymorphisms are specifically expressed in cell types relevant to the traits, implicating these lncRNAs in multiple diseases. We further demonstrate that lncRNAs overlapping expression quantitative trait loci (eQTL)-associated single nucleotide polymorphisms of messenger RNAs are co-expressed with the corresponding messenger RNAs, suggesting their potential roles in transcriptional regulation. Combining these findings with conservation data, we identify 19,175 potentially functional lncRNAs in the human genome.</p><p>The human genome is pervasively transcribed <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> , producing thousands of lncRNAs <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref> . Despite a few well-characterized examples <ref type="bibr" target="#b5">6</ref> , for example MALAT1 (ref. 7), most lncRNAs have low abundance and lack typical signatures of selective constraints <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> . In addition, a substantial fraction of lncRNAs seem to be unstable <ref type="bibr" target="#b7">8</ref> and originate from regulatory regions of other functional units, for example promoter upstream transcripts (PROMPTs) <ref type="bibr" target="#b8">9</ref> and enhancer RNAs <ref type="bibr" target="#b9">10</ref> . Given their diversity in biogenesis <ref type="bibr" target="#b10">11</ref> , their low expression and conservation levels, the functional relevance <ref type="bibr" target="#b11">12</ref> of most lncRNAs remains unclear. Further, at some lncRNA loci it is not their transcripts but the mere act of transcription that is functionally relevant <ref type="bibr" target="#b12">13</ref> . Thus the functionality of these lncRNA loci is more likely to be revealed by assessing the selective constraints <ref type="bibr" target="#b13">14</ref> and genetic variations <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref> within their regulatory regions than their transcript sequences. This emphasizes the need to gather transcript models with accurate 5′ ends. Currently available lncRNA catalogues are, however, mostly derived from RNA sequencing (RNA-seq) assemblies <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> and the 5′ ends of their transcript models are generally inaccurate <ref type="bibr" target="#b17">18</ref> .</p><p>Here we integrate multiple collections of transcript models <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b18">19</ref> with CAGE <ref type="bibr" target="#b19">20</ref> data sets <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> to build an atlas of human lncRNAs with accurate 5′ ends. Having these 5′ complete transcript models allows us to better assess the sequence features and selective constraints at lncRNA loci, and categorize them on the basis of epigenetic marks at their transcription initiation regions (TIRs). We further integrate genetic data sets <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref> with 1,829 expression profiles from the FANTOM5 project <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> (Supplementary Table <ref type="table">1</ref>) to identify potentially functional lncRNAs. Taken together, this study systematically elucidates the diversity of lncRNAs and summarizes the functional relevance of nearly 20,000 lncRNAs as an online resource, which can be further used in prioritizing lncRNA candidates for functional studies.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Building a 5′ complete transcriptome</head><p>To build a 5′ complete transcriptome atlas, we first collected transcript models from GENCODE release 19 (ref. 19), Human BodyMap 2.0 (ref. 4), miTranscriptome <ref type="bibr" target="#b2">3</ref> , ENCODE <ref type="bibr" target="#b1">2</ref> and an RNA-seq assembly from 70 FANTOM5 samples (Extended Data Fig. <ref type="figure" target="#fig_3">1a</ref>, Methods and Supplementary Table <ref type="table">2</ref>). To identify 5′ complete transcript models, we developed the transcription initiation evidence score (TIEScore). For a given pair of CAGE cluster and transcript model, TIEScore evaluates three criteria: (1) the expression level of the CAGE cluster, (2) the distance from the transcript 5′ end to the CAGE cluster and (3) the length and number of exons of a transcript, to determine the likelihood that they identify a genuine transcription start site (TSS) (Supplementary Note 1 and Methods). We next assessed the performance of TIEScore on 70 matched CAGE and RNA-seq data sets on the basis of epigenomic information <ref type="bibr" target="#b22">23</ref> , and found that TIEScore outperformed both CAGE-only and RNA-seq-only approaches in identifying genuine TSSs (Supplementary Note 2 and Methods). We then applied TIEScore to each of the five transcript model collections separately and merged them into a meta-assembly referred to as the FANTOM CAGEassociated transcriptome (FANTOM CAT) (Extended Data Fig. <ref type="figure" target="#fig_3">1a,</ref><ref type="figure">b</ref>). Finally, we defined genes at permissive (n = 124,245), robust (n = 59,110) and stringent (n = 31,520) TIEScore cutoffs (Supplementary Note 3 and Methods). The robust cutoff defines the FANTOM CAT genes used in the remainder of the manuscript (Supplementary Table <ref type="table">3</ref>), unless otherwise specified.</p><p>We next defined 27,919 lncRNA genes in FANTOM CAT on the basis of Coding-Potential Assessment Tool (CPAT) <ref type="bibr" target="#b23">24</ref> scores and GENCODE release 19 annotations <ref type="bibr" target="#b18">19</ref> (Methods and Extended Data Fig. <ref type="figure" target="#fig_3">1b</ref>). The 5′ ends of our lncRNA transcript models show stronger evidence for being genuine TSSs than those in other catalogues (Extended Data Fig. <ref type="figure" target="#fig_3">1d,</ref><ref type="figure">e</ref> and Extended Data Fig. <ref type="figure" target="#fig_4">2a</ref>). Furthermore, the FANTOM CAT catalogue has a lower false discovery rate (FDR) of complete 5′ ends (Extended Data Fig. <ref type="figure" target="#fig_4">2b</ref>) and contains more 5′ complete transcript models (Extended Data Fig. <ref type="figure" target="#fig_4">2c</ref>), as further validated by RAMPAGE data <ref type="bibr" target="#b24">25</ref> (Extended Data Fig. <ref type="figure" target="#fig_4">2d</ref>). Taken together, FANTOM CAT improves the existing lncRNA transcript models (examples in Extended Data Fig. <ref type="figure" target="#fig_1">3</ref> and Supplementary Note 4) and provides the most comprehensive catalogue of human lncRNAs so far.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>lncRNA TIRs</head><p>Next, we categorized lncRNAs on the basis of the overlap between their TSSs and the DNase I hypersensitive sites (DHSs) previously classified as promoter, enhancer or dyadic regulatory regions <ref type="bibr" target="#b22">23</ref> (Fig. <ref type="figure" target="#fig_3">1a</ref> and Extended Data Fig. <ref type="figure" target="#fig_3">1b,</ref><ref type="figure">c</ref>). We found that a large fraction of DHS-supported intergenic lncRNAs (68%) originate from enhancer DHSs (e-lncRNA, Extended Data Fig. <ref type="figure" target="#fig_3">1c</ref>). For lncRNAs originating from promoter DHSs, most (72%), were divergently transcribed from messenger RNA (mRNA) TSS (divergent p-lncRNA, Extended Data Fig. <ref type="figure" target="#fig_3">1c</ref>) as previously observed in mouse erythroblasts <ref type="bibr" target="#b25">26</ref> , and surprisingly only a minority, for example MALAT1 (ref. 7), were intergenic (intergenic p-lncRNA, Extended Data Fig. <ref type="figure" target="#fig_3">1c</ref>). Histone marks at the TIRs of these lncRNA categories recapitulate the epigenomic features of their regulatory regions (Extended Data Fig. <ref type="figure" target="#fig_6">4a</ref>).</p><p>Leveraging the 5′ completeness of FANTOM CAT, we revisited <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b26">27</ref> the analysis of sequence features at TIRs of mRNAs and lncRNAs. First, we examined the overall selective constraints on the basis of rejected substitution score <ref type="bibr" target="#b13">14</ref> . For mRNAs, we observed strongly positive rejected substitution scores at their TSSs and slightly negative scores upstream (Extended Data Fig. <ref type="figure" target="#fig_6">4b</ref>, first row). For divergent p-lncRNAs, we observed a mirrored pattern to their mRNA counterpart, as expected (Extended Data Fig. <ref type="figure" target="#fig_6">4b</ref>, first row). Although intergenic p-lncRNAs and e-lncRNAs showed only slightly positive rejected substitution scores at their TIRs (Extended Data Fig. <ref type="figure" target="#fig_6">4b</ref>, first row), we observed sequence features conducive to generating long transcripts (Extended Data Fig. <ref type="figure" target="#fig_6">4b</ref>, third and fourth rows) and enrichment of motifs involved in transcription initiation (Extended Data Fig. <ref type="figure" target="#fig_6">4c</ref>). Taken together, these suggest that at least a subset of intergenic p-lncRNA and e-lncRNA TIRs have undergone selection for both transcription initiation and elongation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Directionality and stability of lncRNAs</head><p>Transcription initiation is intrinsically bidirectional <ref type="bibr" target="#b27">28</ref> . Functionally distinct RNA species were previously categorized by their transcriptional directionality and by exosome sensitivity <ref type="bibr" target="#b7">8</ref> . For each lncRNA category we examined the relationship between transcriptional directionality, exosome sensitivity and the properties of their transcripts (Supplementary Note 5 and Supplementary Table <ref type="table">4</ref>). We found that most divergent p-lncRNAs are exosome sensitive, short and rarely spliced (that is, PROMPT 9 like), in contrast to intergenic p-lncRNAs, which are less exosome sensitive, longer and more spliced (Supplementary Note 5). In addition, while most e-lncRNA TIRs are bidirectionally transcribed, as previously described <ref type="bibr" target="#b9">10</ref> (Supplementary Note 5), we also identified a subset of unidirectional e-lncRNAs which captures documented functional examples (for example CCAT1, which promotes long-range chromatin looping <ref type="bibr" target="#b28">29</ref> ).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>lncRNA conservation</head><p>We next investigated the conservation of TIRs and exonic regions using rejected substitution scores <ref type="bibr" target="#b13">14</ref> (Fig. <ref type="figure" target="#fig_3">1b</ref> and Methods). Generally, exonic regions from all three lncRNA categories (median ≤ 0.69) were less conserved than mRNAs (median = 3.62), and TIRs of intergenic p-lncRNAs and e-lncRNAs were less conserved than those of divergent p-lncRNAs and mRNAs (Fig. <ref type="figure" target="#fig_3">1b</ref>). Of note, functional examples from lncRNAdb <ref type="bibr" target="#b5">6</ref> fall across all lncRNA categories (Fig. <ref type="figure" target="#fig_3">1b</ref>, circles, and Supplementary Table <ref type="table">5</ref>), and generally have more conserved TIRs and exonic regions (Fig. <ref type="figure" target="#fig_3">1b</ref>, above medians indicated by dashed lines). This could suggest that functional lncRNAs are more conserved but could also reflect the bias during candidate selection for characterization, as conservation has often been used as a criterion to prioritize lncRNAs for functional studies <ref type="bibr" target="#b29">30</ref> .</p><p>We next annotated lncRNAs with conserved TIRs or conserved exonic regions on the basis of their overlap with predefined selectively constrained regions (genomic evolutionary rate profiling (GERP) elements) <ref type="bibr" target="#b13">14</ref> , against random expectations (Fig. <ref type="figure" target="#fig_3">1c</ref>, one-tailed binomial test, P &lt; 0.05, Methods). Under this criterion, 64% of lncRNAs were defined to have either conserved TIRs or conserved exonic regions (Supplementary Table <ref type="table">6</ref>). Examining the overlap between transposons and TIRs revealed the extensive presence of retrotransposons at TIRs (Extended Data Fig. <ref type="figure">5a</ref>, Supplementary Table <ref type="table">7</ref> and Methods). We found that most e-lncRNA (74%) and intergenic p-lncRNA (56%) TIRs overlap retrotransposons (Extended Data Fig. <ref type="figure">5b</ref>). The retrotransposons are significantly enriched in unconserved TIRs of all gene categories (Extended Data Fig. <ref type="figure">5b</ref>, one-tailed Fisher's exact test, P &lt; 0.05), implying the contribution of retrotransposons to the birth of TIRs, in particular of e-lncRNAs and intergenic p-lncRNAs <ref type="bibr" target="#b30">31</ref> .</p><p>As sequence conservation does not imply conserved transcriptional activity across species, we assessed the orthologous transcriptional activity of lncRNA TSSs using CAGE profiles of aortic smooth muscle cells and hepatocytes from human, mouse, rat, dog and chicken (Supplementary Table <ref type="table">8</ref>). Most (&gt;50%) TSSs active in the two human cell types had orthologous sequences in other mammalian species but the extent varied across gene categories, with mRNA TSSs being the most orthologous and intergenic p-lncRNA TSSs the least (Fig. <ref type="figure" target="#fig_3">1d</ref>). Of these orthologous TSSs, varying fractions were active in the matched cell types of other mammalian species: ~85% for mRNAs, ~65% for divergent p-lncRNAs, ~50% for intergenic p-lncRNAs and ~20% for e-lncRNAs (Fig. <ref type="figure" target="#fig_3">1e</ref>). Despite the comparable percentages of orthologous TSSs for p-lncRNAs and e-lncRNAs (Fig. <ref type="figure" target="#fig_3">1d</ref>), the higher levels of conserved activity of p-lncRNAs compared with e-lncRNAs (Fig. <ref type="figure" target="#fig_3">1e</ref>) supports previous observations that the activity of enhancers evolves at a faster pace than that of promoters <ref type="bibr" target="#b31">32</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression specificity of lncRNAs</head><p>To assess the expression specificity of lncRNAs, we calculated their expression level and specificity across 69 primary cell facets 10 (Methods). Despite comparable expression levels across all lncRNA categories, e-lncRNAs were considerably more cell-type-specific (median = 0.44) than p-lncRNAs (median = 0.16 and 0.23) as previously reported <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> (Extended Data Fig. <ref type="figure">6a</ref>). This is reflected in the lower fraction of e-lncRNAs (11.56%) expressed in each facet (Extended Data Fig. <ref type="figure">6b</ref>). On average 5,666 lncRNA genes were found expressed in each facet (Extended Data Fig. <ref type="figure">6c</ref> and Supplementary Table <ref type="table">9</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>lncRNAs implicated in GWAS traits</head><p>Given the cell-type-specific nature of lncRNA expression, the types of cell in which a given lncRNA is specifically expressed may be used as a cue to its functions: for example, lncRNAs playing roles in maintaining pluripotency may be specifically expressed in stem cells <ref type="bibr" target="#b32">33</ref> . Therefore, we identified genes with enriched expression in various tissues and cells on the basis of FANTOM5 sample ontology annotations <ref type="bibr" target="#b20">21</ref> (Supplementary Table <ref type="table">10</ref> and Methods, one-tailed Mann-Whitney rank sum test, P &lt; 0.05). This identified known associations such as enriched expression of the pluripotency-maintaining lncRNA (IncRNA-ES1, ENSG00000226673) <ref type="bibr" target="#b32">33</ref> in embryonic stem cells (CL:0002248). In total, 85% of FANTOM CAT genes were found to have enriched expression in at least one sample ontology term (for simplicity we refer to these as 'cell-type-enriched genes', Supplementary Table <ref type="table">11</ref>).</p><p>Taking advantage of the single nucleotide polymorphisms (SNPs) associated with human traits identified from genome-wide association studies (GWAS) <ref type="bibr" target="#b14">15</ref> and from fine-mapping studies based on probabilistic identification of causal SNPs (PICS) <ref type="bibr" target="#b16">17</ref> (Supplementary Table <ref type="table">12</ref> and Methods), we associated 40.7% of FANTOM CAT genes with at least one trait (for simplicity we refer to these as 'trait-associated genes', Supplementary Table <ref type="table">13</ref>).</p><p>On the basis of these lists of cell-type-enriched and trait-associated genes, we evaluated the association between 345 cell types and 603 traits (208,035 possible pairs) and identified 1,874 pairs of cell types and traits with significant association (Methods, one-tailed Fisher's exact test, FDR &lt; 0.05). A systematic literature curation found that 85% of these pairs were biologically plausible, as opposed to 21% of random control pairs (Supplementary Table <ref type="table">14</ref> and Methods). Unsupervised clustering of significantly associated cell-type-trait pairs revealed that related cell types and traits tended to cluster together (Fig. <ref type="figure" target="#fig_4">2a</ref>). For example, genes associated with neuropathy and behaviour traits significantly overlap genes enriched in nervous system tissues (Fig. <ref type="figure" target="#fig_4">2b</ref>). Other examples showing the associations of traits to immune system, hepato-intestinal system, pigmented cells, non-immune blood cells and cardiovascular system are provided in Extended Data Fig. <ref type="figure">7a-e</ref>. Examining the relative contributions of the four gene categories to the association between nervous system tissues and neuropathy and behaviour traits (Fig. <ref type="figure" target="#fig_4">2c</ref>), we found that the odds ratios of the lncRNA categories are generally comparable to, if not higher than, those of mRNAs, implying that lncRNAs contribute substantially to the specific associations between related cell types and traits. These results thus identified groups of potential functionally related mRNAs and lncRNAs that are active in the same cell types and associated with the same traits, with a total of 5,490 FANTOM CAT genes (including 1,970 lncRNA genes) involved in at least one significantly associated cell-type-trait pair (Fig. <ref type="figure" target="#fig_4">2d</ref> and Supplementary Table 15). Some associations between cell types and traits involve mainly protein-coding genes: for example, the association between cardial valve (UBERON:0000946) and shortened PR interval (HP:0005165) involves only protein-coding genes (TBX5, NKX2-5, XIRP1, SCN5A and ITGA9). Of note, TBX5, NKX2-5 and SCN5A have previously been implicated in the trait <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref> . In contrast, other associations between cell types and traits involve larger fractions of lncRNAs: for example, the association between middle temporal gyrus (UBERON:0002771) and autism spectrum disorder (DOID:0060041) involves 18 lncRNAs out of 49 genes. Another example is the e-lncRNA AP001057.1 (ENSG00000232124), which is associated with multiple immune traits, enriched in classical monocytes (CL:0000860) and induced upon treatment with various microbial agents (Extended Data Fig. <ref type="figure">8</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Selective constraint and SNP enrichment</head><p>The function of some lncRNAs, for example Lockd in mouse <ref type="bibr" target="#b36">37</ref> , has been attributed to the act of transcription rather than to the transcripts themselves <ref type="bibr" target="#b12">13</ref> . To evaluate the functional relevance of the regulatory and transcribed regions of lncRNA, we examined selective constraint and enrichment of GWAS <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b16">17</ref> and eQTL <ref type="bibr" target="#b15">16</ref> SNPs within DHS (that is, regulatory) and exonic (that is, transcribed) regions. We first evaluated the selective constraints in terms of sequence conservation across species (phastCons score <ref type="bibr" target="#b37">38</ref> ) and variation within populations (derived allele frequency 39 ). We found DHSs of all gene categories to be more selectively constrained than their corresponding exons both across species and within populations (Extended Data Fig. <ref type="figure" target="#fig_2">9a</ref>, Methods). We also noticed that the DHSs with CAGE support are generally more constrained than those lacking CAGE support (Extended Data Fig. <ref type="figure" target="#fig_2">9</ref>, third column).</p><p>We next evaluated the enrichment of GWAS and PICS SNPs <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b16">17</ref> (Extended Data Fig. <ref type="figure" target="#fig_2">9b,</ref><ref type="figure">c</ref> and Methods). For all gene categories, we observed higher levels of GWAS SNP enrichment at DHSs than their corresponding exons (Extended Data Fig. <ref type="figure" target="#fig_2">9b</ref>). Regardless, both GWAS and PICS SNPs were still enriched (above the background) at exons of all gene categories (Extended Data Fig. <ref type="figure" target="#fig_2">9b,</ref><ref type="figure">c</ref>). As expression of lncRNAs is typically more cell-type-specific, we also performed a focused analysis for genes enriched in immune cells and associated with PICS SNPs of immune traits (that is, immune versus immune, Extended Data Fig. <ref type="figure" target="#fig_2">9c</ref>). For all regions and across all gene categories (except intergenic p-lncRNAs), we observed higher enrichments for the focused (immune versus immune) analysis compared with the global (all versus all) analysis (Extended Data Fig. <ref type="figure" target="#fig_2">9c</ref>, in particular exons of e-lncRNAs). This result highlights the importance of considering cell-type specificity when assessing enrichment of trait-associated SNPs, as well as the functional relevance of the exons of e-lncRNAs.</p><p>Finally, we evaluated the enrichment of eQTL-associated SNPs (GTEx SNPs associated with mRNA expression levels <ref type="bibr" target="#b15">16</ref> , Methods) at lncRNA loci (Extended Data Fig. <ref type="figure" target="#fig_2">9d</ref>). As expected, the DHSs of mRNAs and divergent p-lncRNAs showed the strongest enrichment as they overlap the regulatory regions of mRNAs. Interestingly, we observed modest, but significant (Student's t-test, P &lt; 0.05), enrichment in both DHSs and exons of intergenic p-lncRNAs and e-lncRNAs, suggesting these lncRNAs might potentially affect the expression of nearby mRNAs, similar to cis-acting ncRNA-activating RNAs <ref type="bibr" target="#b39">40</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>lncRNAs implicated in eQTL</head><p>Given the enrichment of eQTL-associated SNPs at lncRNA loci (Extended Data Fig. <ref type="figure" target="#fig_2">9d</ref>), we next evaluated the expression correlation of lncRNA-mRNA pairs linked by eQTLassociated SNPs (Fig. <ref type="figure" target="#fig_5">3a</ref> and Methods) separated by various distances (Fig. <ref type="figure" target="#fig_5">3b</ref>) and linked by varying numbers of SNPs (Fig. <ref type="figure" target="#fig_5">3c</ref>). The results showed that eQTL-linked lncRNA-mRNA pairs were generally more co-expressed than the corresponding sets of control random pairs. We observed that the correlation decreases with the distance (Fig. <ref type="figure" target="#fig_5">3b</ref>, significant when distance ≥ 10 1.5 kilobases (kb), paired Student's t-test, P &lt; 0.05) and increases with the number of SNPs (Fig. <ref type="figure" target="#fig_5">3c</ref>, significant for all cases, paired Student's t-test, P &lt; 0.05). This analysis thus identified a subset of significantly co-expressed (Methods, binomial test, P &lt; 0.05) eQTL-linked lncRNA-mRNA pairs (n = 5,264 pairs involving 3,166 lncRNAs, Supplementary Table <ref type="table">16</ref> and Fig. <ref type="figure" target="#fig_5">3d</ref> for an example). Interestingly, we observed similar above-background levels of co-expression in eQTL-linked mRNA-mRNA pairs (Extended Data Fig. <ref type="figure" target="#fig_3">10a</ref>), as well as in all categories of lncRNA (Extended Data Fig. <ref type="figure" target="#fig_3">10c-e</ref>). Moreover, the phenomenon appears to be independent of the orientation of the gene pair and locations of the SNPs (Extended Data Fig. <ref type="figure" target="#fig_3">10b</ref>, across the columns). Therefore, these observations might represent a general mode of co-regulation between neighbouring transcribing loci, independent of types and orientations of the loci, which is in agreement with a recent publication showing that mRNA promoters can act as enhancers of neighbouring genes <ref type="bibr" target="#b12">13</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>We compiled an atlas of human lncRNAs with the most accurate 5′ ends and the broadest collection of expression profiles so far. High-confidence 5′ ends of our transcript models allowed detailed analyses of their regulatory regions and revealed that lncRNAs are more conserved than previously appreciated. It highlighted that intergenic p-lncRNAs, such as MALAT1 (ref. 7), are a minority compared with intergenic e-lncRNAs and divergent p-lncRNAs. Despite their heterogeneous biogenesis, and their potential to be promiscuous byproducts of transcription (from enhancers <ref type="bibr" target="#b9">10</ref> and divergent from mRNA promoters <ref type="bibr" target="#b8">9</ref> ), all three categories of lncRNAs have documented functional examples in lncRNAdb <ref type="bibr" target="#b5">6</ref> . Assessing the functional relevance of lncRNAs, we identified lncRNAs with conserved exons (n = 13,896), conserved TIRs (n = 13,228), implicated in GWAS traits (n = 1,970) and implicated in eQTL (n = 3,166) (Supplementary Table <ref type="table">17</ref> and Fig. <ref type="figure" target="#fig_6">4a</ref>). We observed modest, but significant, enrichment of conserved lncRNAs in the sets of lncRNAs implicated in GWAS traits and eQTL (Fig. <ref type="figure" target="#fig_6">4b</ref>, one-tailed Fisher's exact test, P &lt; 0.05), and found that it positively correlates with the level of conservation (Fig. <ref type="figure" target="#fig_6">4c</ref>, Pearson's r = 0.98). These observations support the notion that selectively more constrained lncRNAs are more likely to be functional, although it does not exclude the potential functionality of lncRNAs with weaker selective constraints. Taken together, our analyses provide further evidence of the potential functionality of 69% of the FANTOM CAT lncRNAs (n = 19,175 of 27,919), advancing the current scientific debate on the functional relevance <ref type="bibr" target="#b11">12</ref> of pervasive transcription from mammalian genomes <ref type="bibr" target="#b40">41</ref> . To what extent the remaining 31% represents spurious transcription initiation by RNA polymerase II <ref type="bibr" target="#b41">42</ref> is still an open question. Although most of the lncRNAs detected here are likely to originate from genuine TSSs (Supplementary Note 6), additional studies are needed to completely understand their biogenesis and assess their functionality. To this end, we have summarized their expression patterns, genomic features, conservation and intersection with genetic data into a comprehensive resource (<ref type="url" target="http://fantom.gsc.riken.jp/cat/">http://fantom.gsc.riken.jp/ cat/</ref>). This encompasses a web application to retrieve gene-, trait-and cell-type-based information and ZENBU <ref type="bibr" target="#b42">43</ref> views for visualizing genomic data. We anticipate wide applications of this resource in prioritizing lncRNA candidates for further elucidation of their functions, which is continuing in the sixth iteration of FANTOM (<ref type="url" target="http://fantom.gsc.riken.jp/6/">http:// fantom.gsc.riken.jp/6/</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head><p>No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genome version</head><p>Analyses in this study were performed on genome version hg19 (GRCh37) for human, mm9 for mouse, rn6 for rat, canFam3 for dog and galGal4 for chicken.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human ethics</head><p>All human samples examined in this study were either exempted material or were obtained with informed consent and covered under ethics applications H17-34 and H21-14 to the RIKEN Yokohama Ethics IRB.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FANTOM5 RNA-seq libraries of human samples</head><p>Seventy samples from diverse biological sources (Supplementary Table <ref type="table">2</ref>) exhibiting potential for discovery of novel genes (large proportion of 'orphan' CAGE clusters with no association to known gene models) were profiled using random primed RNA-seq. All total RNA samples (except the whole blood) underwent ribosomal depletion using a Ribo-Zero rRNA removal kit (Epicentre, Illumina). The whole blood, CD19 + B cells and CD8 + T cells were polyA + selected using Dynabeads Oligo(dT) 25 (Life Technologies). (RNA extraction details have been described <ref type="bibr" target="#b20">21</ref> .) Strand-specific, 100 bp single-end RNA-seq libraries were generated at RIKEN GeNAS (as described <ref type="bibr" target="#b9">10</ref> ) and sequenced on an Illumina HiSeq2000 platform to a depth of ~200 million reads each.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assembly of FANTOM5 RNA-seq</head><p>Raw reads were processed via the Moirai pipeline <ref type="bibr" target="#b43">44</ref> and included adaptor clipping and removing of low-quality reads and ribosomal RNA sequences (rRNAdust version 1.02 (ref. 44)). Individual libraries were mapped onto hg19 using TopHat (version 1.4.1) <ref type="bibr" target="#b44">45</ref> and assembled using Cufflinks (version 1.3.0) <ref type="bibr" target="#b44">45</ref> with default parameters and de novo assembled using Trinity (version r2012-01-25) <ref type="bibr" target="#b45">46</ref> with default parameters. De novo transcripts were aligned to the genome with BLAT <ref type="bibr" target="#b46">47</ref> (only transcripts with 96% identity and with alternative mapping score within 5% of the best scoring location were kept). Alignment gaps ≤3 bp were considered as mismatches and assemblies with non-canonical splicing junctions were discarded. The splice junctions from these Cufflinks and Trinity assemblies were combined and used in a second iteration of assembly. Specifically, reads from individual libraries were re-mapped onto hg19 using TopHat (version 1.4.1) <ref type="bibr" target="#b44">45</ref> by supplying these combined splicing junctions and Cufflinks2 (version 2.0.2) <ref type="bibr" target="#b44">45</ref> was used for assembling individual libraries. These individual assemblies were merged into the final assembly (FANTOM5 RNA-seq assembly) using Cuffmerge (version 1.0.0) <ref type="bibr" target="#b44">45</ref> . Read counts and corresponding expression levels for each transcript in each of the 70 libraries were estimated using Sailfish (version 0.6.3) <ref type="bibr" target="#b47">48</ref> with default parameters.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transcript model collections from published assemblies</head><p>Transcript models from GENCODE release 19 (ref. 19) (<ref type="url" target="http://www.gencodegenes.org/">http://www.gencodegenes.org/</ref>) and miTran-scriptome 3 assemblies (<ref type="url" target="http://mitranscriptome.org/">http://mitranscriptome.org/</ref>) were downloaded and used as is. Cuffmerge (version 1.0.0) <ref type="bibr" target="#b44">45</ref> was used to merge transcript models provided by the Human BodyMap 2.0 (ref. 4) (<ref type="url" target="ftp://ftp.broadinstitute.org/Transcriptome_Assemblies/">ftp://ftp.broadinstitute.org/Transcriptome_Assemblies/</ref>) and transcript models from total, polyA + and polyA -RNA assemblies generated by ENCODE 2 .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FANTOM5 CAGE clusters</head><p>A CAGE cluster (CAGE peaks, corresponding to TSS regions) was defined by the 'decomposition peak identification' method as described in our previous study <ref type="bibr" target="#b20">21</ref> (<ref type="url" target="http://fantom.gsc.riken.jp/5/data/">http:// fantom.gsc.riken.jp/5/data/</ref>). To expand the coverage of lowly abundant transcripts and to assure the identifier compatibility with our previous studies <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> , the 'FANTOM5 phase 1 + 2 robust' CAGE clusters <ref type="bibr" target="#b26">27</ref> (n = 201,802) were used and then the non-overlapping FANTOM5 phase 2 unfiltered CAGE clusters (n = 4,218,430) were added. Only the CAGE clusters with at least three reads (sum among 1,897 FANTOM5 samples) were retained. This produced a set of 3,339,568 CAGE clusters used in all analyses in this study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rationale of TIEScore</head><p>TIEScore evaluates the properties of a pair of CAGE cluster and transcript model to determine the likelihood they identify a genuine TSS, in terms of estimated DHS validation rates (see Supplementary Note 1 for details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gold standard TSS and non-TSS regions based on chromatin states</head><p>Gold standard TSS and non-TSS regions were defined on the basis of chromatin states estimated by chromHMM <ref type="bibr" target="#b48">49</ref> among from Roadmap Epigenomics Consortium <ref type="bibr" target="#b22">23</ref> and FANTOM5 CAGE clusters <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> (see Supplementary Note 2 for details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Benchmark of TIEScore using matched CAGE and RNA-seq libraries</head><p>Using 70 samples with matched CAGE and RNA-seq libraries, the performance of TIEScore was compared against CAGE or RNA-seq read count alone, in identification of genuine TSSs (see Supplementary Note 2 for details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Meta-assembly of FANTOM CAT</head><p>TIEScore was first applied to each of the five transcript model collections separately and then merged into a non-redundant transcript set (referred to as raw FANTOM CAT) (see Supplementary Note 1 for details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Validation of TSS using DHS and RAMPAGE data sets</head><p>The definition of DHS was based on Roadmap Epigenome Consortium <ref type="bibr" target="#b29">30</ref> . The TSS of a transcript (that is, its 5′ end) or a CAGE cluster (that is, its most prominent TSS) was defined as validated if it overlapped a DHS. TSS validations by DHS were performed on transcripts and CAGE clusters, grouped by bins of TIEScore in Supplementary Fig. <ref type="figure" target="#fig_5">3b</ref> or TIEScore criteria values in Supplementary Fig. <ref type="figure" target="#fig_3">1b</ref>. RAMPAGE <ref type="bibr" target="#b24">25</ref> data sets (n = 207) were downloaded <ref type="bibr" target="#b49">50</ref> and used to validate the TSSs of transcripts. A transcript was defined as 'detected by RAMPAGE' if the 3′ ends of at least three RAMPAGE fragments overlapped its exon. The TSS of a detected transcript was defined as 'validated by RAMPAGE' if the 5′ end of an exon-overlapping RAMPAGE fragment was found in close proximity, ranging from 0 to 100 bp in Supplementary Fig. <ref type="figure" target="#fig_5">3c</ref> or 0 to 500 bp in Extended Data Fig. <ref type="figure" target="#fig_4">2d</ref>, representing various stringencies of TSS validation. TSS validations by RAMPAGE were performed on transcripts grouped by bins of TIEScore in Supplementary Fig. <ref type="figure" target="#fig_5">3c</ref>, and lncRNA and CCDS transcripts of various transcript catalogues in Extended Data Fig. <ref type="figure" target="#fig_4">2d</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reducing the isoform complexity of raw FANTOM CAT</head><p>Low-abundance transcript isoforms (associated with the same CAGE cluster) were removed to reduce the complexity of FANTOM CAT. Specifically, the abundance (in fragments per kilobase per millions, FPKM) was estimated for each transcript in raw FANTOM CAT across 107 RNA-seq libraries (37 ENCODE libraries <ref type="bibr" target="#b49">50</ref> and 70 FANTOM5 libraries, Supplementary Table <ref type="table">2</ref>) using Sailfish (version 0.6.3) <ref type="bibr" target="#b47">48</ref> and is represented by the 75th percentile of its FPKM across these libraries. For each of the CAGE clusters the abundance of all of its associated transcripts was summed and the non-GENCODE (version 19) transcripts with &lt; 10% of the sum were removed. All GENCODE (version 19) transcripts within a CAGE cluster were retained. Only the top five most abundant non-GENCODE (version 19) transcripts within a CAGE cluster were retained. (Note: all CAGE clusters in raw FANTOM CAT were retained.)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition and classification of FANTOM CAT genes</head><p>FANTOM CAT genes were defined on the basis of clustering of transcript models in raw FANTOM CAT and all genes were assigned to one of the 11 classes defined on the basis of coding potential and genomic context (see Supplementary Note 4 for details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Annotation of open reading frames in FANTOM CAT</head><p>Coordinates of open reading frames on all FANTOM CAT transcripts were extracted using getorf <ref type="bibr" target="#b50">51</ref> . The coding potentials of these open reading frames were assessed using PhyloCSF <ref type="bibr" target="#b51">52</ref> , RNAcode <ref type="bibr" target="#b52">53</ref> , and ribosome profiling data in sorfs.org (ref. 54) (see Supplementary Note 4 for details).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison of lncRNAs with other lncRNA catalogues</head><p>Three lncRNA catalogues, GENCODE release 25 (ref. 5) lncRNAs on hg19, Human BodyMap 2.0 (ref. 4) lncRNAs and miTranscriptome 3 lncRNAs, were compared with lncRNAs of FANTOM CAT. The non-redundant 5′ end regions (±50 nt) of all transcripts in each of these catalogues and the FANTOM CAT catalogues (permissive, robust and stringent) were extracted and their FDRs on complete 5′ ends were calculated using the 10 sets of gold standard TSS and non-TSS regions with N ranging from 10 to 100 in steps of 10 (Extended Data Fig. <ref type="figure" target="#fig_4">2b</ref>). The number of lncRNA genes with genuine 5′ ends was estimated as (1 -FDR) × number lncRNA genes in each of the catalogues (Extended Data Fig. <ref type="figure" target="#fig_4">2c</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of genes originating from promoter, enhancer and dyadic regulatory regions</head><p>The definition of DNaseI-accessible regulatory regions is based on the Roadmap Epigenome Consortium <ref type="bibr" target="#b22">23</ref> (<ref type="url" target="http://egg2.wustl.edu/roadmap/web_portal/DNase_reg.html">http://egg2.wustl.edu/roadmap/web_portal/DNase_reg.html</ref>). A gene is defined as originating from promoter, enhancer or dyadic DHS when its strongest TSS is located within the corresponding type of DHS.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of unannotated genomic regions</head><p>Unannotated genomic regions were defined as the whole-genome regions excluding exonic and intronic regions of GENCODE release 25 (ref. 19) genes, DHS ranges of Roadmap Epigenome Consortium <ref type="bibr" target="#b22">23</ref> and annotated gaps.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CpG island, polyadenylation signal, 5′ splicing sites, TATA-box and initiator motifs around TIRs</head><p>Locations of CpG islands were obtained from the University of California, Santa Cruz (UCSC) genome browser <ref type="bibr" target="#b54">55</ref> . The position weight matrix (PWM) of motifs 5′ splicing site (5′SS, SD0001.1), TATA-box (POL012.1) and initiator (POL002.1) were obtained from JASPAR (<ref type="url" target="http://jaspar.genereg.net/">http://jaspar.genereg.net/</ref>). The PWMs of polyadenylation signal (PAS) were constructed on the basis of the annotated PAS in GENCODE release 19 (ref. 19). The locations of these motifs on hg19 were predicted on the basis of their PWM using HOMER (<ref type="url" target="http://homer.salk.edu/homer/">http://homer.salk.edu/homer/</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Directionality, splicing index, genomic span and exosome sensitivity</head><p>We examined the relationship between the directionality of CAGE clusters and the properties of their transcripts as described in Supplementary Note 5.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of conserved TIRs and exons in FANTOM CAT</head><p>The TIR of a gene was defined as the region from -609 to +604 bp of its strongest TSS, based on the median distance between all TSSs and the boundaries of their overlapping DHSs. The exonic region of a gene was defined as the merged exonic regions of its associated transcripts. The strength of selective constraints on genomic regions was measured on the basis of rejected substitution score from GERP <ref type="bibr" target="#b13">14</ref> . For each TIR and exonic region of a gene, the 200 bp window yielding the highest per-nucleotide score was considered (Fig. <ref type="figure" target="#fig_3">1b</ref>). Conserved TIRs and exons were defined (as in Fig. <ref type="figure" target="#fig_3">1c</ref>) on the basis of their overlaps (≥50 bp) with the highest-scoring GERP elements <ref type="bibr" target="#b13">14</ref> as follows. TIR or exonic regions were defined as conserved when the observed value (score of the highest-scoring GERP elements) was greater than 50% (one-tailed binomial test, P &lt; 0.05) of the values from 100 random permutations (that is, regions of the same sizes randomly sampled from unannotated genomic regions). Each gene was thus classified as one of the following scenarios: (1) both TIR and exon conserved, (2) TIR conserved only, (3) exon conserved only, or (4) unconserved. Most lncRNAs (divergent p-lncRNA: 81.9%, intergenic p-lncRNA: 57.8% and e-lncRNA: 63.8%) were defined to have either conserved TIRs or exons, versus 94.6% for mRNAs (Fig. <ref type="figure" target="#fig_3">1c</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of transposable elements</head><p>We annotated repeat elements in hg19 using RepeatMasker (4.0.3), nhmmer (hmmer-3.1b1) <ref type="bibr" target="#b55">56</ref> and Dfam (1.2) <ref type="bibr" target="#b56">57</ref> . It has been reported that screening for repeat elements using nhmmer and Dfam is more sensitive and specific than consensus sequence-based approaches <ref type="bibr" target="#b56">57</ref> . Specifically, we ran the command 'RepeatMasker -e hmmer -species humans -xsmall -pa 8 chr.fa', for each assembled chromosome. Repeat elements were classified by class, family and individual element names as provided by Dfam. The TIR of a gene was defined as 'transposable element overlapping' when it intersects with the transposable element with at least 1 bp. Enrichment of transposable-element-overlapping TIRs in unconserved TIRs was tested using a one-tailed Fisher's exact test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FANTOM5 CAGE libraries of rat, dog and chicken samples</head><p>RNA and cell samples of hepatocytes and aortic smooth muscle cells of rat, dog and chicken (Supplementary Table <ref type="table">1</ref>) were purchased from Cell Applications (CAC35405, CACn35405, CAR35405, CAR780K30 s, CA354-R10a, M354-20, chicken hepatocytes were a custom order), Sciencell (SC5205), Celsis (F00205, M00205) and BD Gentest (454830). CAGE libraries were prepared on the Helicos platform and analysed as described previously <ref type="bibr" target="#b9">10</ref> , except that mapping of the CAGE reads was done against the rat (rn6), dog (canFam3) and chicken (galGal4) genomes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conservation of TSS activities</head><p>The most prominent TSS of each FANTOM CAT CAGE cluster on hg19 was projected onto the genomes of mouse (mm9), rat (rn6), dog (canFam3) and chicken (galGal4) using the UCSC liftover tool <ref type="bibr" target="#b54">55</ref> . A human TSS was defined as orthologous when it could be projected onto the genomes of other species (Fig. <ref type="figure" target="#fig_3">1d</ref>). An orthologous human TSS was considered active in another species when the projected TSS (±50 nt) contained ≥5 CAGE reads in the same cell type (Fig. <ref type="figure" target="#fig_3">1e</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Calculation of expression levels of CAGE clusters and genes</head><p>The expression levels of CAGE clusters and genes of FANTOM CAT were calculated for all FANTOM5 samples (Supplementary Table <ref type="table">1</ref>). For each CAGE cluster a flanking region of ±50 nt to its most prominent TSS was defined for read counting. For pairs of CAGE clusters with their most prominent TSSs located within 100 nt of each other, the region between the two TSSs was equally divided to avoid any overlapping flanking regions. The numbers of CAGE read 5′ ends (CAGE TSS) falling within the flanking region of each CAGE cluster in each CAGE library were counted, and the expression levels of CAGE clusters were relative log expression (rle) normalized across all libraries as counts per million (cpm) using edgeR (version 3.6.8) <ref type="bibr" target="#b57">58</ref> with default settings. Gene-based expression levels were calculated as the sum of counts per million of their associated CAGE clusters.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression specificity of genes across primary cell facets</head><p>FANTOM5 primary cell samples <ref type="bibr" target="#b20">21</ref> were grouped as non-overlapping facets (n = 69) as previously described <ref type="bibr" target="#b9">10</ref> (Supplementary Table <ref type="table">1</ref>). The expression level of a gene in a facet was represented by its maximum counts per million calculated across all individual samples within this facet (Extended Data Fig. <ref type="figure">6a</ref>). The expression specificity of a gene across the primary cell facets was represented by Chao-Shen corrected Shannon's entropy <ref type="bibr" target="#b58">59</ref> and calculated as a ratio of the sum of read counts within each facet to the sum of read counts in all facets (Extended Data Fig. <ref type="figure">6a</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identification of dynamically expressed lncRNAs</head><p>Differential expression analysis was performed on 25 sets of FANTOM5 experiments where cells were subjected to stimulation or underwent differentiation (20 time course experiments from FANTOM5 'Phase 2' 22 and 5 paired control and treatment experiments from FANTOM5 'Phase 1' 21 , Supplementary Table <ref type="table">18</ref>). The read count of a gene in each sample was calculated as the sum of read counts of its associated CAGE clusters. For each experiment, a group of samples was defined as the reference (for example, initial time point of a time course) and the other groups were defined as the queries. Queries were tested for differential expression against the reference set using edgeR (version 3.6.8) <ref type="bibr" target="#b57">58</ref> with default settings. A gene was defined as 'dynamically regulated' when it was significantly differentially expressed (FDR &lt; 0.05) in at least one comparison (Supplementary Table <ref type="table">19</ref>). An example is shown in Extended Data Fig. <ref type="figure" target="#fig_2">9c</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample ontology annotations of FANTOM5 samples</head><p>A set of non-redundant sample ontology terms <ref type="bibr" target="#b20">21</ref> describing the originating cells (n = 173, Cell Ontology terms <ref type="bibr" target="#b59">60</ref> ) and tissues (n = 174, Uberon terms 61 ) of 744 FANTOM5 samples was selected on the basis of manual curation of the set of sample ontology terms we published previously <ref type="bibr" target="#b20">21</ref> (<ref type="url" target="http://fantom.gsc.riken.jp/5/datafiles/latest/extra/Ontology/">http://fantom.gsc.riken.jp/5/datafiles/latest/extra/Ontology/</ref>). Each curated sample ontology term is associated with a unique set of samples and the overrepresentation of similar samples within a term is kept minimal, for example samples from multiple adjacent time points in a time course. The association between each sample ontology term and the 744 FANTOM5 samples can be found in Supplementary Table <ref type="table">10</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of cell-type-enriched genes</head><p>FANTOM CAT genes were defined as enriched in particular cells and tissues by examining their expression in samples annotated with sample ontology terms 21 as described above. A gene was defined as enriched in a sample ontology term when (1) its mean expression was five times higher in samples of that ontology than in other samples, (2) it was detected in at least 50% of the samples of that ontology, and (3) P &lt; 0.05 in a one-tailed Mann-Whitney rank sum test. Only sample ontology terms with at least two samples profiled in FANTOM5 were considered. This defined 49,979 of 59,110 FANTOM CAT genes to be enriched in at least one sample ontology term (that is, cell-type-enriched genes: 15,791 coding genes, 23,766 lncRNA genes and 7,422 other genes, Supplementary Table <ref type="table">11</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Processing of trait-associated SNPs</head><p>Trait-associated SNPs were taken from (1) GWASdb 15 for genome-wide association studies SNPs (GWAS lead SNPs) (as of 28 June 2015, <ref type="url" target="http://jjwanglab.org/gwasdb">http://jjwanglab.org/gwasdb</ref>) and ( <ref type="formula">2</ref>) probabilistic identification of causal SNPs 17 (PICS) for fine-mapped SNPs (PICS SNPs) (<ref type="url" target="http://pubs">http://pubs</ref>. broadinstitute.org/pubs/finemapping/). The PICS set contains 8,741 SNPs associated with 39 traits. For the GWASdb set, only the lead SNPs with P &lt; 1 × 10 -5 were used. The GWASdb traits from multiple redundant classifications of disease ontology (DOID), human phenotype ontology (HP), Medical Subject Headings (MeSH) and experiment factor ontology (EFO) terms were manually curated and removed to minimize redundancy. The SNPs within the linkage disequilibrium block of the GWAS lead SNPs (that is, proxy SNPs) were searched for using SNAP (version 2.2) <ref type="bibr" target="#b61">62</ref> (<ref type="url" target="https://www.broadinstitute.org/mpg/snap/">https:// www.broadinstitute.org/mpg/snap/</ref>) with an r 2 threshold of 0.8 and distance limit of 500 kb in any of the three population panels of the 1000 Genomes Project pilot data <ref type="bibr" target="#b62">63</ref> . The proxy SNP coordinates were mapped from hg18 to hg19 using the UCSC liftOver tool <ref type="bibr" target="#b54">55</ref> , resulting in a set of 868,536 GWAS proxy SNPs. The final set of trait-associated SNPs (8,741 PICS SNPs, 72,919 lead GWAS SNPs and 868,536 proxy GWAS SNPs) was associated with 39 and 788 traits from PICS <ref type="bibr" target="#b16">17</ref> and GWASdb <ref type="bibr" target="#b14">15</ref> , respectively (Supplementary Table <ref type="table">12</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definition of trait-associated genes</head><p>A gene was defined as associated with a trait when its 5′ end regions (-800 to +200 nt of the most prominent TSS of all of its associated CAGE clusters) or genic regions (all exons and the size-limited introns (≤ 11 kb) of its associated transcripts) overlapped at least one trait-associated SNP. As fewer than 10% of human mRNA introns were shown to be longer than 11 kb (ref. 64), introns exceeding this length were excluded to minimize assembly artefacts. This defined 24,059 of 59,110 FANTOM CAT genes to be associated with at least one trait (that is, trait-associated genes: 11,836 coding genes, 9,595 lncRNA genes and 2,628 other genes, Supplementary Table <ref type="table">13</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association between cell-type-enriched genes and trait-associated genes</head><p>For each pair of cell types and traits, the significance of their association was evaluated. Specifically, for each pair, the genes associated (1) only with either the cell type or the trait (single positives), ( <ref type="formula">2</ref>) with both the cell type and the trait (double positives) and ( <ref type="formula">3</ref>) with neither the cell type nor the trait (double negatives) were counted and tested for the significance of association (one-tailed Fisher's exact test). The pair of cell type and trait was considered significantly associated when (1) FDR &lt; 0.05 (P values adjusted for multiple testing within a trait using BH method) and (2) at least 10% of the trait-associated genes were double positives. Only cell types and traits associated with at least 25 genes were tested. The tests were performed for all genes together (Fig. <ref type="figure" target="#fig_4">2a</ref>) and for each of the four gene categories separately for neural block in Fig. <ref type="figure" target="#fig_4">2c</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clustering of cell types and traits</head><p>Cell types and traits were clustered (Fig. <ref type="figure" target="#fig_4">2a</ref>) on the basis of the pairwise Pearson's correlation of log(1/FDR) of the one-tailed Fisher's exact test (scaled as Z-score within each trait) using the R package Pheatmap (clustering method = complete). In Fig. <ref type="figure" target="#fig_4">2a</ref>, colour bars were added to summarize the six manually curated biological themes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Curation of significantly associated cell-type-trait pairs</head><p>For each pair of significantly associated cell types and traits, their physiological relevance was manually curated by literature mining. Blind controls were randomly selected from 300 non-associated cell-type and trait pairs and added to the curation list (Supplementary Table <ref type="table">14</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Selective constraints and enrichment of SNPs</head><p>In Extended Data Fig. <ref type="figure" target="#fig_2">9</ref>, DHS regions of a gene category were defined as regions of all DHS associated with the genes of the category. Exon regions of a gene category were defined as 'merged' exonic regions of its genes and excluding its DHS regions (generated using Bedtools version 2.20.1 (ref. 65)). For positive control DHS regions, the promoter and enhancer DHS from Roadmap Epigenome Consortium <ref type="bibr" target="#b22">23</ref> were divided into CAGE-supported and non-CAGE supported ones on the basis of their overlap with all FANTOM5 clusters <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> . For positive control exon regions, we used the merged exonic regions of GENCODE release 25 mRNAs and lncRNAs. For negative control regions, 100,000 1-kb windows were randomly sampled from the whole genome and from unannotated genomic regions. In Extended Data Fig. <ref type="figure" target="#fig_2">9a</ref>, selective constraints in these region sets were based on measurements of 100,000 randomly sampled windows from each set of regions; conservation across interspecies: per base PhastCons score from placental mammals on the basis of a 46-way alignments <ref type="bibr" target="#b65">66</ref> ; variations within population: per SNP-derived allele frequencies based on 1000 Genomes Project data 39 . In Extended Data Fig. <ref type="figure" target="#fig_2">9b,</ref><ref type="figure">c</ref>, GWAS lead and PICS SNPs were defined as described. In Extended Data Fig. <ref type="figure" target="#fig_2">9d</ref>, eQTL-associated SNPs of mRNA were obtained from GTEx <ref type="bibr" target="#b15">16</ref> (data release version 6p, pooled from all 44 tissues) and only SNPs associated with the expression variation of protein coding genes at P &lt; 1 × 10 -5 were retained. These SNPs are referred to as foreground SNPs. SNPdb version 142 (from the UCSC Genome Browser <ref type="bibr" target="#b54">55</ref> ) was used to define the background SNPs for PICS and eQTL-associated SNPs. For GWAS lead SNPs, all SNPs on two popular SNPs array platforms (Affymetrix version 6 and Illumina 550, from the UCSC Genome Browser 55 ) were used as background SNPs. Enrichment of foreground SNPs in each set of regions was evaluated by first counting the number of the foreground and background SNPs intersecting these regions (as observed fore and observed back ), then the counting was repeated for 100 permutations (regions of the same sizes shuffled into unannotated genomic regions, as shuffled fore and shuffled back ). The odds ratio of foreground SNP enrichment for each round of permutation was calculated as (observed fore /observed back )/(shuffled fore /shuffled back ). As a control, the analysis was repeated by replacing the foreground SNPs with randomly chosen background SNPs. In Extended Data Fig. <ref type="figure" target="#fig_2">9c</ref>, to test for cell-type specificity of traits, the process was repeated only with a subset of genes enriched in immune cells (as defined above) and associated with PICS SNPs of immune traits (that is, immune versus immune, focused analysis).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Co-expression between lncRNA-mRNA pairs linked by eQTL-associated SNPs</head><p>eQTL SNPs of mRNA were obtained as described above (GTEx <ref type="bibr" target="#b15">16</ref> data release version 6p). A pair of lncRNA and mRNA was defined as 'linked by eQTL' if the 5′ end region (-800 to +200 nt of its strongest TSS) or the genic region (exons and introns) of the lncRNA overlapped with at least one eQTL-associated SNP of the mRNA. The pairs with the lncRNA divergently transcribed from the mRNA TSS or overlapping with mRNA on the same strand were defined as positional dependent and discarded. As negative controls, the same number of lncRNA-mRNA pairs on different chromosomes (trans random pairs) and on the same chromosome with matched distance and orientation (non-linked, distance and orientation matched cis random pairs) were randomly sampled. The Spearman correlation was calculated for the expression profiles of each lncRNA-mRNA pair across the 1,829 FANTOM5 samples (Supplementary Table <ref type="table">1</ref>). The distance between the pair was defined as the distance between their strongest TSSs. The extent of co-expression (measured by absolute Spearman's rho) of the eQTL-linked lncRNA-mRNA pair, at various distances between the pair (Fig. <ref type="figure" target="#fig_5">3b</ref>) and number of SNPs linking the pair (Fig. <ref type="figure" target="#fig_5">3c</ref>), was compared with that of non-linked, distance and orientation matched cis random pairs. eQTL-linked lncRNA-mRNA pairs were found to be significantly more co-expressed (P &lt; 0.05, paired Student's t test) in all cases except when distances between the pair were less than 10 1.5 kb (asterisks in Fig. <ref type="figure" target="#fig_5">3b</ref>). To define significantly co-expressed individual eQTL-linked lncRNA-mRNA pairs, the absolute Spearman's rho of each lncRNA-mRNA pair was compared with that of 100 non-linked, distance-and orientation-matched cis random pairs (that is, matched background correlation). An eQTL-linked lncRNA-mRNA pair was defined as 'implicated in eQTL' when (1) the distance between the pair was ≥ 10 1.5 kb and (2) the pair were significantly more co-expressed than the 75th percentile of the matched background correlation (one-tailed binomial test, P &lt; 0.05).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Enrichment of conserved lncRNAs in lncRNAs implicated in eQTL and GWAS traits</head><p>In Fig. <ref type="figure" target="#fig_6">4</ref>, 'Conserved lncRNAs' were defined as lncRNAs with conserved TIRs or conserved exons as in Fig. <ref type="figure" target="#fig_3">1</ref>. 'LncRNAs implicated in GWAS traits' and 'lncRNAs implicated in eQTL' were defined as in Fig. <ref type="figure" target="#fig_0">2</ref> and Fig. <ref type="figure" target="#fig_1">3</ref>, respectively. Enrichment of conserved lncRNAs in the lists of lncRNAs implicated in eQTL and GWAS traits was investigated using a onetailed Fisher's exact test. 'Level of conservation' refers to the score of the most conserved GERP element <ref type="bibr" target="#b13">14</ref> within the TIR or exon of an lncRNA (bin = 1,500). 'Level of enrichment' refers to the odds ratio of lncRNAs at a certain level of conservation to be implicated in eQTL or GWAS traits based on a one-tailed Fisher's exact test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Web resource</head><p>FANTOM CAT web resource was developed using the AngularJS JavaScript framework (<ref type="url" target="https://angularjs.org/">https://angularjs.org/</ref>), the D3js visualization library <ref type="bibr" target="#b66">67</ref> (<ref type="url" target="http://d3js.org/">http://d3js.org/</ref>) and additional frontend modules and development tools from Project-chi (<ref type="url" target="https://github.com/Hypercubed/Project-Chi">https://github.com/Hypercubed/ Project-Chi</ref>). An online version of the resource is located at <ref type="url" target="http://fantom.gsc.riken.jp/cat/">http://fantom.gsc.riken.jp/cat/</ref>. The source code (under MIT license) is available at <ref type="url" target="https://github.com/Hypercubed/fantom-cat/">https://github.com/Hypercubed/fantom-cat/</ref>. The genomic context of FANTOM CAT genes is visualized with ZENBU <ref type="bibr" target="#b42">43</ref> (an interactive visualization and analysis integrated web-service).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability</head><p>The FANTOM CAT meta-assembly and its related resources can be found at <ref type="url" target="http://fantom.gsc.riken.jp/cat/">http:// fantom.gsc.riken.jp/cat/</ref>. The CAGE data generated in this study have been deposited in DDBJ (<ref type="url" target="http://trace.ddbj.nig.ac.jp/">http://trace.ddbj.nig.ac.jp/</ref>) under accession codes DRA004812, DRA004813 and DRA004814 (Supplementary Table <ref type="table">1</ref>). The RNA-seq data generated in this study have been deposited in DDBJ under accession codes DRA001101 and DRA004790 (Supplementary Table <ref type="table">2</ref>). Previously published FANTOM5 CAGE data can be found in DDBJ under accession codes DRA000991, DRA001026, DRA001027, DRA001028, DRA002216, DRA002711, DRA002747, DRA002748 and DRA005089 (Supplementary Table <ref type="table">1</ref>). Sample information is available through the FANTOM5 resource browser SSTAR <ref type="bibr" target="#b67">68</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Extended Data</head><p>Extended Data Figure <ref type="figure" target="#fig_3">1</ref> |. Building a 5′ complete lncRNA catalogue. a, Integration of CAGE and transcript models. CAGE clusters were used to integrate transcript models from various sources and their 5′ completeness was assessed on the basis of TIEScore. b, Identification of lncRNAs. TIEScore identified 59,110 genes and coding potential assessment further identified 27,919 lncRNAs in FANTOM CAT at the robust TIEScore cutoff. c, Categorization of lncRNAs. LncRNAs were annotated according to their gene orientation (that is, genomic context) and DHS type <ref type="bibr" target="#b22">23</ref> (that is, epigenomic context) and then categorized into divergent p-lncRNAs (purple), intergenic p-lncRNAs (blue), e-lncRNAs (green) and other lncRNAs (grey). d, Overlaps between FANTOM CAT and other lncRNA catalogues. e, LncRNA gene models outside FANTOM CAT are 5′ incomplete. LncRNAs found commonly in both catalogues (grey), or only in FANTOM CAT (red), show stronger evidence of transcription initiation (DHS, H3K4me1, H3K4me3 and PolII ChIPseq <ref type="bibr" target="#b22">23</ref> ) and conservation (phastCons <ref type="bibr" target="#b37">38</ref> ) than those found only in other lncRNA catalogues (blue, green or yellow). for control (right). The exon of a transcript is detected by RAMPAGE <ref type="bibr" target="#b30">31</ref> if it overlaps ≥3 RAMPAGE 3′ ends. Transcript detection rates of all catalogues were plotted (upper). About 95% of lncRNA transcripts in the robust FANTOM CAT can be detected, which is slightly higher than that of GENCODE release 25 (~92%). The TSS of a detected transcript is validated by RAMPAGE if it is located within the proximity of a RAMPAGE 5′ end (for example, from 0 to 500 bp, x axis, lower). At 100 bp, ~95% of lncRNA transcripts in the robust FANTOM CAT can be validated, versus ~85% for that of GENCODE release 25. We note the percentages of CCDS transcripts in FANTOM CAT and GENCODE release 25 detected or validated by RAMPAGE are similar, with the robust and stringent FANTOM CAT catalogues performing slightly better. A detailed view of blocks from Fig. <ref type="figure" target="#fig_4">2a</ref>. The dendrograms were coloured as in Fig. <ref type="figure" target="#fig_4">2a</ref>. a, 'Immune system' cell types and 'infection and immunity' traits. b, 'Hepato-intestinal system' cell types and 'hepatic function' traits. c, 'Pigmented cells' cell types and 'pigmentation' traits. d, 'Non-immune blood cells' cell types and 'blood homeostasis' traits. e, 'Cardiovascular system' cell types and 'cardiovascular function' traits.</p><p>Extended Data Figure <ref type="figure">8</ref> |. LncRNA AP001057.1 is associated with classical monocytes and implicated in immune diseases. a, Genomic view of AP001057.1 (ENSG00000232124) in the ZENBU genome browser <ref type="bibr" target="#b42">43</ref> . The strongest TSS of AP001057.1 overlaps with an enhancer DHS. The locus overlaps with fine-mapped SNPs associated with Crohn's disease and GWAS SNPs associated with coeliac disease and inflammatory bowel disease. b, AP001057.1 is associated with classical monocytes (CL:0000860). c, AP001057.1 is significantly upregulated in monocytes upon stimulation with various immunogenic agents (FDR &lt; 0.05 in edgeR <ref type="bibr" target="#b57">58</ref> , highlighted in red and indicated with asterisks). Note: we performed differential expression analysis to identify lncRNAs that are dynamically regulated upon stimulation, infection or differentiation on the basis of 25 manually curated series of FANTOM5 samples (Supplementary Table <ref type="table">18</ref> and Methods), and the results are available in Supplementary Table <ref type="table">19</ref>. Figures were captured (with slight modifications) from the online resource at <ref type="url" target="http://fantom.gsc.riken.Jp/cat/v1/#/genes/ENSG00000232124.1">http://fantom.gsc.riken.Jp/cat/v1/#/ genes/ENSG00000232124.1</ref>. We searched for gene loci that overlap eQTL SNPs associated with expression variation of mRNAs (as identified by GTEx <ref type="bibr" target="#b15">16</ref> ). Gene loci overlapping these SNPs were then paired with the corresponding mRNA and their expression correlation across the FANTOM5 expression atlas was investigated. Rows compare the gene types overlapping the SNPs. a, mRNAs; b, all lncRNAs; c, divergent p-lncRNAs; d, intergenic p-lncRNAs; e, e-lncRNAs. Columns compare the relative orientation of the gene pairs and the position of the SNPs. The term 'all' refers to all orientations of the gene pairs and positions of the SNPs pooled. Gene pairs were binned on the basis of the number of SNPs linking the pair (bin = 5 SNPs). The data points represent the mean of absolute Spearman's rho and the error bars represent its 99.99% confidence intervals. At each bin, the number of pairs plotted is the same for the three pair types as indicated.  a, Unsupervised clustering of cell types and traits based on the association of cell-typeenriched genes with trait-associated genes. All lncRNAs and all other genes were used. Only cell types and traits involved in significantly associated cell-type-trait pairs were plotted. Intensity represents the level of association measured as Z-score of the log-transformed FDR reciprocal in one-tailed Fisher's exact test. Cell types and traits were clustered on the basis of the Z-score. Selected cell types and traits of six matching themes were colour-coded accordingly. Clusters for specific themes are highlighted in the dendrograms (Extended Data Fig. <ref type="figure">7</ref> for detailed views). b, Detailed view of the neural block, showing significant association of genes enriched in nervous system tissues and genes associated with neuropathy and behaviour traits. c, Contributions of gene categories within the neural block. Odds ratios were calculated on the basis of all genes, or other gene categories as indicated. d, Number of genes contributing to significantly associated cell-type-trait pairs.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Extended Data</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Extended Data Figure 2 |</head><label>2</label><figDesc>. FANTOM CAT is more 5′ complete than other lncRNA catalogues. a, FANTOM CAT lncRNA TSS are well-supported. The 5′ ends of FANTOM CAT lncRNAs (first column) have stronger transcriptomic, epigenomic and genomic evidence of transcription initiation than the 5′ ends of lncRNA models in the Human BodyMap 2.0 (ref. 4), miTranscriptome 3 and GENCODE release 25 (ref. 19) (second column). In b and c, the box plots show the median, quartiles and Tukey whiskers of the estimates of FDR of complete 5′ ends (b) and number of 5′ complete lncRNA genes (c) on the basis of ten sets of gold standard TSS and non-TSS regions (Methods). b, FDR of complete 5′ ends. c, Estimated number of 5′ complete lncRNA genes (total number of genes × [1 -FDR]). d, Validation rate of gene models using RAMPAGE. RAMPAGE data sets 25,50 (n = 207, Methods) were used to validate the lncRNA transcripts in FANTOM CAT and other catalogues (left). Transcripts containing full consensus CDS (CCDS transcripts) were used</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Extended Data Figure 3 |</head><label>3</label><figDesc>. Revision of lncRNA models in GENCODE. a, An example of improved TSS annotation of a GENCODE release 25 lncRNA gene. The 5′ ends of GENCODE release 25 annotated lncRNA transcripts of TUG1 (ENSG00000253352) are distant from the region of strong CAGE signal, while FANTOM CAT added extra transcripts accurately start from the proximal CAGE signal summit. b, An example of bridged gene models of GENCODE release 25 lncRNA genes. In GENCODE release 25, the locus was annotated with three short lncRNA genes; FANTOM CAT bridged these short lncRNA transcript models into a long transcript model (RP11-973H7.4, ENSG00000267654) starting from the proximal CAGE signal summit. Extended Data Figure 4 |. Heterogeneity among lncRNA gene categories. a, Epigenomic features surrounding TSS. The y axis refers to the fraction of TIR overlaps with peaks of the corresponding epigenomic signal from the Roadmap Epigenome Consortium 23 . b, Genomic features surrounding TSS. Sequence features conducive to generating longer transcripts are enrichment of 5′ splice site (5′ SS) and depletion of polyadenylation sites (PAS). Sequence features associated with transcription initiation include CpG islands, INR (initiator) motif and TATA box motif. c, Core promoter motifs. Grey dashed lines indicate whole-genome background. Extended Data Figure 5 |. Transposons at TIRs. a, Percentages of genes with conserved and unconserved TIR (as defined in Fig. 1c) and their overlap with various classes of transposons. b, Enrichment of retrotransposons at unconserved TIR. The Venn diagrams show the overlap between unconserved TIR, DNA transposons and retrotransposons. Retrotransposons are significantly enriched in unconserved TIR of all gene classes (one-tailed Fisher's exact test, P &lt; 0.05). Extended Data Figure 6 |. Expression landscape of lncRNAs in primary cells. a, Expression level and specificity. Abbreviation cpm is relative log expression (rle) normalized count per millions. The maximum expression level (log 2 cpm) and expression specificity (Chao-Shen's corrected Shannon entropy 59 ) of genes among 69 primary cell facets 10 were plotted. Box plots show the median (dashed lines), quartiles and Tukey whiskers. b, Percentage of genes within categories expressed within primary cell facets. The circles represent the mean among samples within a facet and the error bars represent 99.99% confidence intervals. Dashed lines represent the means among all samples. c, Number of lncRNA genes expressed within primary cell facets. Dashed line represents the mean among Extended Data Figure 7 |. Association of cell-type-enriched genes with trait-associated genes of different biological themes.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 9 |</head><label>9</label><figDesc>. Selective constraints and enrichment of GWAS trait and eQTLassociated SNPs at lncRNA loci. a, Selective constraints between species (phastCons 38 ) and within human population (derived allele frequency 39 ). b, Enrichment of GWAS SNPs. Only lead GWAS SNPs 15 were used (Methods). c, Enrichment of PICS 17 fine-mapped SNPs in global (all versus all) or focused (immune versus immune) analysis (Methods). d, Enrichment of GTEx eQTL SNPs 16 associated with expression of mRNAs. Circles represent means and the error bars represent their 99.99% confidence intervals. Extended Data Figure 10 |. Co-expression of various gene pairs linked by eQTL SNPs.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 1 |</head><label>1</label><figDesc>Figure 1 |. Conservation of lncRNAs. a, Categories of lncRNAs. b, Rejected substitution (RS) scores 14 . Per-nucleotide values of the highest scoring window (200 nt) were plotted. Box plots show the median (dashed lines), quartiles and Tukey whiskers. Circles indicate functional lncRNAs from lncRNAdb 6 . The filled, half-filled and empty circles represent different TIR and exon conservation scenarios as in c. c, Percentages of genes (grey scale) defined to have conserved TIR, exon or both, based on GERP elements 14 . d, Percentages of all orthologous human TSSs. e, Percentages of active orthologous human TSSs.</figDesc><graphic coords="36,144.48,62.00,383.04,290.04" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 2 |</head><label>2</label><figDesc>Figure 2 |. Cell-type-specific lncRNAs implicated in GWAS traits.</figDesc><graphic coords="37,84.00,62.00,504.00,336.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 3 |</head><label>3</label><figDesc>Figure 3 |. LncRNAs implicated in eQTL. a, Rationale of the analysis. Expression correlation of lncRNA-mRNA pairs (b) binned on the basis of distances between the pair and (c) binned on the basis of the number of eQTLassociated SNPs 16 linking the pair. Circles represent the mean of absolute Spearman's rho and the error bars represent their 99.99% confidence intervals. Asterisks indicate that the absolute Spearman's rho for the eQTL-linked pairs is significantly higher than that of nonlinked, distance-and orientation-matched cis random pairs (paired Student's t-test, P &lt; 0.05). d, Co-expression of an eQTL-linked lncRNA-mRNA pair; cpm, counts per million.</figDesc><graphic coords="38,192.07,62.00,287.85,236.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 4 |</head><label>4</label><figDesc>Figure 4 |. Functional evidence of human lncRNAs. a, Venn diagram showing lncRNAs with conserved exon, conserved TIR, implicated in eQTL or implicated in GWAS traits. b, Enrichment of lncRNAs with conserved exon or TIR in lncRNAs implicated in eQTL or GWAS traits. 'OR' and 'P' refer to odds ratio and P value of one-tailed Fisher's exact test. c, Level of conservation versus level of enrichment in lncRNAs implicated in eQTL or GWAS traits. Asterisks indicate lncRNAs at certain levels of conservation are significantly enriched in lncRNAs implicated in eQTL or GWAS traits (one-tailed Fisher's exact test, P &lt; 0.05).</figDesc><graphic coords="39,192.08,62.00,287.84,222.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="23,193.08,62.00,285.84,503.37" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="24,94.44,62.00,483.12,337.39" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc>at http:// fantom.gsc.riken.jp/5/sstar/Browse_samples. The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files. Source data for all figures, Extended Data figures and Supplementary Figures are provided in the online version of the paper.</figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>Nature. Author manuscript; available in PMC 2019 November 15.</p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgements</head><p>FANTOM5 was made possible by research grants for the <rs type="institution">RIKEN Omics Science Center</rs> and the <rs type="institution">Innovative Cell Biology by Innovative Technology</rs> (<rs type="programName">Cell Innovation Program</rs>) from the <rs type="funder">MEXT</rs> to <rs type="person">Y.H. It</rs> was also supported by research grants for the <rs type="funder">RIKEN Preventive Medicine and Diagnosis Innovation Program (RIKEN PMI</rs>) to Y.H. and the <rs type="funder">RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)</rs>) from the <rs type="funder">MEXT Japan</rs>. A.R.R.F. is supported by a <rs type="grantName">Senior Cancer Research Fellowship</rs> from the <rs type="funder">Cancer Research Trust</rs>, the <rs type="funder">MACA Ride to Conquer Cancer</rs> and the <rs type="funder">Australian Research Council's Discovery Projects funding scheme</rs> (<rs type="grantNumber">DP160101960</rs>). S.D. is supported by award number <rs type="grantNumber">U54HG007004</rs> from the <rs type="funder">National Human Genome Research Institute of the National Institutes of Health</rs>, funding from the <rs type="funder">Ministry of Economy and Competitiveness (MINECO)</rs> under grant number <rs type="grantNumber">BIO2011-26205</rs>, and <rs type="grantNumber">SEV-2012-0208</rs> from the <rs type="funder">Spanish Ministry of Economy and Competitiveness</rs>. Y.A. <ref type="figure">M</ref>. is supported by the <rs type="funder">Russian Science Foundation</rs>, grant <rs type="grantNumber">15-14-30002</rs>. We thank <rs type="person">RIKEN GeNAS</rs> for generation of the CAGE and RNA-seq libraries, the <rs type="funder">Netherlands Brain Bank</rs> for brain materials, the <rs type="institution">RIKEN BioResource Centre</rs> for providing cell lines and all members of the <rs type="institution">FANTOM5 consortium</rs> for discussions, in particular <rs type="person">H. Ashoor</rs>, <rs type="person">M. Frith</rs>, <rs type="person">R. Guigo</rs>, <rs type="person">A. Tanzer</rs>, <rs type="person">E. Wood</rs>, <rs type="person">H. Jia</rs>, <rs type="person">K. Bailie</rs>, <rs type="person">J. Harrow</rs>, <rs type="person">E. Valen</rs>, <rs type="person">R. Andersson</rs>, <rs type="person">K. Vitting-Seerup</rs>, <rs type="person">A. Sandelin</rs>, <rs type="person">M. Taylor</rs>, <rs type="person">J. Shin</rs>, <rs type="person">R. Mori</rs>, <rs type="person">C. Mungall</rs> and <rs type="person">T. Meehan</rs>.</p></div>
			</div>
			<div type="funding">
<div><p>conceived the project and managed <rs type="funder">FANTOM5</rs>. The scientific coordinator was A.R.R.F. and the general organizer was Y.H.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_grvBY3f">
					<orgName type="program" subtype="full">Cell Innovation Program</orgName>
				</org>
				<org type="funding" xml:id="_FC9jAHJ">
					<orgName type="grant-name">Senior Cancer Research Fellowship</orgName>
				</org>
				<org type="funding" xml:id="_kyEtKfp">
					<idno type="grant-number">DP160101960</idno>
				</org>
				<org type="funding" xml:id="_UNXvkDB">
					<idno type="grant-number">U54HG007004</idno>
				</org>
				<org type="funding" xml:id="_XjuCJur">
					<idno type="grant-number">BIO2011-26205</idno>
				</org>
				<org type="funding" xml:id="_S75Nk6D">
					<idno type="grant-number">SEV-2012-0208</idno>
				</org>
				<org type="funding" xml:id="_hx5WXMd">
					<idno type="grant-number">15-14-30002</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p>Refer to Web version on PubMed Central for supplementary material.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The transcriptional landscape of the mammalian genome</title>
		<author>
			<persName><forename type="first">P</forename><surname>Carninci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="1559" to="1563" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16141072</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Landscape of transcription in human cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Djebali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">489</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22955620</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The landscape of long noncoding RNAs in the human transcriptome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Iyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="199" to="208" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25599403</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Cabili</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1915" to="1927" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21890647</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression</title>
		<author>
			<persName><forename type="first">T</forename><surname>Derrien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1775" to="1789" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22955988</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">C</forename><surname>Quek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="168" to="D173" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25332394</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Schmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Thorac. Oncol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<date type="published" when="1984">1984-1992 (2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22088988</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Nuclear stability and transcriptional directionality separate functionally distinct RNA species</title>
		<author>
			<persName><forename type="first">R</forename><surname>Andersson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Commun</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">5336</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25387874</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">RNA exosome depletion reveals transcription upstream of active human promoters</title>
		<author>
			<persName><forename type="first">P</forename><surname>Preker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="1851" to="1854" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 19056938</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">An atlas of active enhancers across human cell types and tissues</title>
		<author>
			<persName><forename type="first">R</forename><surname>Andersson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">507</biblScope>
			<biblScope unit="page" from="455" to="461" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24670763</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Unique features of long non-coding RNA biogenesis and function</title>
		<author>
			<persName><forename type="first">Jj &amp;</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Rev. Genet</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="47" to="62" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26666209</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">RNA: what is functional and what is junk?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Palazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><surname>Non</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front. Genet</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">2</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25674102</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Local regulation of gene expression by lncRNA promoters, transcription and splicing</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Engreitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">539</biblScope>
			<biblScope unit="page" from="452" to="455" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27783602</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Identifying a high fraction of the human genome to be under selective constraint using GERP++</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Davydov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Comput. Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">1001025</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 21152010</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">GWASdb v2: an update database for human genetic variants identified by genomewide association studies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="869" to="D876" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26615194</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans</title>
		<author>
			<persName><forename type="first">Consortium</forename><surname>Gtex</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="648" to="660" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25954001</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Genetic and epigenetic fine mapping of causal autoimmune disease variants</title>
		<author>
			<persName><forename type="first">Kk-H</forename><surname>Farh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">518</biblScope>
			<biblScope unit="page" from="337" to="343" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25363779</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Assessment of transcript reconstruction methods for RNA-seq</title>
		<author>
			<persName><forename type="first">T</forename><surname>Steijger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Methods</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1177" to="1184" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24185837</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">GENCODE: the reference human genome annotation for The ENCODE Project</title>
		<author>
			<persName><forename type="first">J</forename><surname>Harrow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1760" to="1774" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22955987</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shiraki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="15776" to="15781" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 14663149</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A promoter-level mammalian expression atlas</title>
		<author>
			<persName><forename type="first">Arr</forename><surname>Forrest</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">507</biblScope>
			<biblScope unit="page" from="462" to="470" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24670764</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells</title>
		<author>
			<persName><forename type="first">E</forename><surname>Arner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="1010" to="1014" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25678556</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">518</biblScope>
			<biblScope unit="page" from="317" to="330" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25693563</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page">74</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23335781</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Gingeras TR High-fidelity promoter profiling reveals widespread alternative promoter usage and transposon-driven developmental gene expression</title>
		<author>
			<persName><forename type="first">P</forename><surname>Batut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dobin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Plessy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carninci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="169" to="180" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 22936248</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Sigova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="2876" to="2881" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23382218</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Genome-wide analysis of mammalian promoter architecture and evolution</title>
		<author>
			<persName><forename type="first">P</forename><surname>Carninci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="626" to="635" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16645617</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Core</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1311" to="1320" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25383968</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus</title>
		<author>
			<persName><forename type="first">J-F</forename><surname>Xiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="513" to="531" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24662484</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Ulitsky I Evolution to the rescue: using comparative genomics to understand long non-coding RNAs</title>
	</analytic>
	<monogr>
		<title level="j">Nature Rev. Genet</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="601" to="614" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27573374</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kapusta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1003470</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23637635</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Enhancer evolution across 20 mammalian species</title>
		<author>
			<persName><forename type="first">D</forename><surname>Villar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="554" to="566" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25635462</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors</title>
		<author>
			<persName><forename type="first">S-Y</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R &amp;</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Stanton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="522" to="533" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22193719</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Several common variants modulate heart rate, PR interval and QRS duration</title>
		<author>
			<persName><forename type="first">H</forename><surname>Holm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="117" to="122" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20062063</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Genome-wide association study of PR interval</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pfeufer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="153" to="159" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20062060</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Rhythm</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="634" to="641" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19389651</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Unlinking an lncRNA from its associated cis element</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Paralkar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="104" to="110" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27041223</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Siepel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1034" to="1050" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16024819</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">An integrated map of genetic variation from 1,092 human genomes</title>
		<author>
			<persName><forename type="first">Genomes</forename><surname>Project</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Consortium</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="page" from="56" to="65" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23128226</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Activating RNAs associate with Mediator to enhance chromatin architecture and transcription</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">494</biblScope>
			<biblScope unit="page" from="497" to="501" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23417068</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The reality of pervasive transcription</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Biol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1000625</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21765801</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Struhl K Transcriptional noise and the fidelity of initiation by RNA polymerase II</title>
	</analytic>
	<monogr>
		<title level="j">Nature Struct. Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="103" to="105" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17277804</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Interactive visualization and analysis of large-scale sequencing datasets using ZENBU</title>
		<author>
			<persName><forename type="first">J</forename><surname>Severin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Biotechnol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="217" to="219" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24727769</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<author>
			<persName><forename type="first">A</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Daub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carninci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hayashizaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lassmann</surname></persName>
		</author>
		<author>
			<persName><surname>Moirai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">compact workflow system for CAGE analysis</title>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">144</biblScope>
		</imprint>
	</monogr>
	<note>PubMed: 24884663</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Trapnell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Biotechnol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="511" to="515" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20436464</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Full-length transcriptome assembly from RNA-Seq data without a reference genome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Grabherr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Biotechnol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="644" to="652" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21572440</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Kent WJ BLAT--the BLAST-like alignment tool</title>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="656" to="664" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 11932250</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms</title>
		<author>
			<persName><forename type="first">R</forename><surname>Patro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Mount</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kingsford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Biotechnol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="462" to="464" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24752080</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">automating chromatin-state discovery and characterization</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kellis</surname></persName>
		</author>
		<author>
			<persName><surname>Chromhmm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Methods</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="215" to="216" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22373907</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">ENCODE data at the ENCODE portal</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Sloan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26527727</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Longden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bleasby</surname></persName>
		</author>
		<author>
			<persName><surname>Emboss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Molecular Biology Open Software Suite. Trends Genet</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="276" to="277" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10827456</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jungreis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kellis</surname></persName>
		</author>
		<author>
			<persName><surname>Phylocsf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">a comparative genomics method to distinguish protein coding and non-coding regions</title>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="275" to="282" />
		</imprint>
	</monogr>
	<note>PubMed: 21685081</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">RNAcode: robust discrimination of coding and noncoding regions in comparative sequence data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Washietl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">RNA</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="578" to="594" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21357752</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">org: a repository of small ORFs identified by ribosome profiling</title>
		<author>
			<persName><forename type="first">V</forename><surname>Olexiouk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="324" to="D329" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26527729</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">The human genome browser at UCSC</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Kent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="996" to="1006" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12045153</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wheeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Eddy</surname></persName>
		</author>
		<author>
			<persName><surname>Nhmmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">DNA homology search with profile HMMs. Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2487" to="2489" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23842809</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Dfam: a database of repetitive DNA based on profile hidden Markov models</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wheeler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="70" to="D82" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23203985</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Bioconductor package for differential expression analysis of digital gene expression data</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mccarthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Smyth</surname></persName>
		</author>
		<author>
			<persName><surname>Edger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="139" to="140" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 19910308</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Nonparametric estimation of Shannon&apos;s index of diversity when there are unseen species in sample</title>
		<author>
			<persName><forename type="first">A</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T-J</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ. Ecol. Stat</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="429" to="443" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Logical development of the cell ontology</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Meehan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">6</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21208450</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">an integrative multispecies anatomy ontology</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mungall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Torniai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Gkoutos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Haendel</surname></persName>
		</author>
		<author>
			<persName><surname>Uberon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">5</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22293552</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2938" to="2939" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18974171</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">1000 Genomes Project Consortiumet al. A map of human genome variation from population-scale sequencing</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">467</biblScope>
			<biblScope unit="page" from="1061" to="1073" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20981092</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Chow VTK &amp; Kangueane P Distributions of exons and introns in the human genome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Sakharkar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">In Silico Biol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="387" to="393" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 15217358</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Hall IM BEDTools: a flexible suite of utilities for comparing genomic features</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Quinlan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="841" to="842" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20110278</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Rosenbloom KR &amp; Siepel A Detection of nonneutral substitution rates on mammalian phylogenies</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Pollard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Hubisz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="110" to="121" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 19858363</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">data-driven documents</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bostock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ogievetsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Heer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Trans. Vis. Comput Graph</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="2301" to="2309" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 22034350</note>
</biblStruct>

<biblStruct xml:id="b67">
	<monogr>
		<title level="m" type="main">FANTOM5 transcriptome catalog of cellular states based on Semantic MediaWiki</title>
		<author>
			<persName><forename type="first">I</forename><surname>Abugessaisa</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016. 2016</date>
			<biblScope unit="page">105</biblScope>
		</imprint>
	</monogr>
	<note>PubMed: 27402679</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
